• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

弥散性血管内凝血的凝血和纤溶平衡。

Coagulation and fibrinolysis balance in disseminated intravascular coagulation.

机构信息

Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan.

出版信息

Pediatr Int. 2021 Nov;63(11):1311-1318. doi: 10.1111/ped.14684. Epub 2021 Oct 26.

DOI:10.1111/ped.14684
PMID:33660897
Abstract

BACKGROUND

Sepsis is a common underlying disease associated with disseminated intravascular coagulation (DIC). We have recently determined hemostatic pathological states at diagnosis through simultaneous assessment of coagulation and fibrinolysis potentials in sepsis-associated DIC using clot-fibrinolysis waveform analysis. Here we aimed to investigate hemostatic pathological states, focusing on the balance between coagulation and fibrinolysis dynamics during the clinical course in pediatric sepsis-associated DIC.

METHODS

Coagulation and fibrinolysis potential functions in three pediatric patients with sepsis-associated DIC during their clinical course were quantified using clot-fibrinolysis waveform analysis. A maximum coagulation velocity (|min1|) and maximum fibrinolysis velocity (|FL-min1|) was calculated as a ratio relative to normal plasma.

RESULTS

In case 1, coagulation-enhanced and fibrinolysis-depressed state (|min1|-ratio 2.22 and |FL-min1|-ratio 0.42) was observed on day 1. This discrepancy significantly reduced after anticoagulant therapy and plasma exchange on day 2. A well-balanced hemostatic state (0.70 and 0.62, respectively) was restored on day 7. In case 2, fibrinolysis-impaired state (|min1|-ratio 1.09 and |FL-min1|-ratio 0.21) was seen on day 1. The |min1| ratio was slightly prolonged and the |FL-min1| ratio was severely decreased. Both were restored on day 7 and returned to normal levels on day 12. In case 3, twofold coagulation- and fibrinolysis-enhanced states (|min1|-ratio 1.99 and |FL-min1|-ratio 1.11) were seen on day 1. However, both potentials rapidly decreased on day 2 (0.49 and 0.0, respectively). She died on day 5.

CONCLUSIONS

The hemostatic pathological states in sepsis-associated DIC depend on disease progression. Comprehensive assessment of coagulation-fibrinolysis potentials over time may therefore be helpful in considering optimal treatment plans for sepsis-associated DIC.

摘要

背景

脓毒症是一种常见的基础疾病,与弥漫性血管内凝血(DIC)有关。我们最近通过使用血栓-纤维蛋白溶解波型分析同时评估脓毒症相关 DIC 中的凝血和纤维蛋白溶解潜能,确定了 DIC 的止血病理状态。在此,我们旨在研究止血病理状态,重点关注儿科脓毒症相关 DIC 患者临床病程中凝血和纤维蛋白溶解动力学之间的平衡。

方法

使用血栓-纤维蛋白溶解波型分析量化了 3 例脓毒症相关 DIC 患儿在其临床病程中的凝血和纤维蛋白溶解潜能功能。计算最大凝血速度(|min1|)和最大纤维蛋白溶解速度(|FL-min1|),并相对于正常血浆进行了比值计算。

结果

在病例 1 中,在第 1 天观察到凝血增强和纤维蛋白溶解受抑状态(|min1|-比值为 2.22,|FL-min1|-比值为 0.42)。在第 2 天接受抗凝治疗和血浆置换后,这种差异显著减少。在第 7 天,恢复了平衡的止血状态(分别为 0.70 和 0.62)。在病例 2 中,在第 1 天观察到纤维蛋白溶解受损状态(|min1|-比值为 1.09,|FL-min1|-比值为 0.21)。|min1|比值略有延长,|FL-min1|比值严重降低。两者均在第 7 天恢复,在第 12 天恢复正常水平。在病例 3 中,在第 1 天观察到两倍的凝血和纤维蛋白溶解增强状态(|min1|-比值为 1.99,|FL-min1|-比值为 1.11)。然而,这两种潜能在第 2 天迅速下降(分别为 0.49 和 0.0)。她于第 5 天死亡。

结论

脓毒症相关 DIC 的止血病理状态取决于疾病进展。因此,随着时间的推移对凝血-纤维蛋白溶解潜能进行全面评估可能有助于考虑脓毒症相关 DIC 的最佳治疗方案。

相似文献

1
Coagulation and fibrinolysis balance in disseminated intravascular coagulation.弥散性血管内凝血的凝血和纤溶平衡。
Pediatr Int. 2021 Nov;63(11):1311-1318. doi: 10.1111/ped.14684. Epub 2021 Oct 26.
2
A Pathological Clarification of Sepsis-Associated Disseminated Intravascular Coagulation Based on Comprehensive Coagulation and Fibrinolysis Function.基于全面凝血和纤溶功能的脓毒症相关弥散性血管内凝血的病理阐释
Thromb Haemost. 2020 Sep;120(9):1257-1269. doi: 10.1055/s-0040-1713890. Epub 2020 Jul 17.
3
The effects of emicizumab on in vitro coagulation and fibrinolysis parameters in patients with disseminated intravascular coagulation with and without addition of anti-FVIII antibody.emicizumab 对伴有和不伴有抗 FVIII 抗体的弥漫性血管内凝血患者体外凝血和纤溶参数的影响。
Haemophilia. 2024 May;30(3):836-844. doi: 10.1111/hae.14997. Epub 2024 Mar 24.
4
The balance of comprehensive coagulation and fibrinolytic potential is disrupted in patients with moderate to severe COVID-19.在中重度 COVID-19 患者中,全面凝血和纤维蛋白溶解潜能的平衡被打破。
Int J Hematol. 2022 Jun;115(6):826-837. doi: 10.1007/s12185-022-03308-w. Epub 2022 Feb 16.
5
Hemostatic function in hyperfibrinolytic disseminated intravascular coagulation.高纤溶状态下弥散性血管内凝血的止血功能
Pediatr Int. 2019 Sep;61(9):872-881. doi: 10.1111/ped.13919.
6
Clinical investigation of the utility of a pair of coagulation-fibrinolysis markers for definite diagnosis of sepsis-induced disseminated intravascular coagulation: A single-center, diagnostic, prospective, observational study.凝血-纤溶标志物对脓毒症诱导的弥散性血管内凝血明确诊断的临床研究:一项单中心、诊断、前瞻性、观察性研究。
Thromb Res. 2020 Aug;192:116-121. doi: 10.1016/j.thromres.2020.05.009. Epub 2020 May 11.
7
Disseminated intravascular coagulation: an update on pathogenesis and diagnosis.弥散性血管内凝血:发病机制与诊断的最新进展
Expert Rev Hematol. 2018 Aug;11(8):663-672. doi: 10.1080/17474086.2018.1500173. Epub 2018 Jul 20.
8
Hemostatic study before onset of disseminated intravascular coagulation.弥散性血管内凝血发作前的止血研究。
Am J Hematol. 1993 Jul;43(3):190-4. doi: 10.1002/ajh.2830430306.
9
Disseminated Intravascular Coagulation: The Past, Present, and Future Considerations.弥散性血管内凝血:过去、现在及未来的思考
Semin Thromb Hemost. 2022 Nov;48(8):978-987. doi: 10.1055/s-0042-1756300. Epub 2022 Sep 13.
10
Global fibrinolytic capacity in pediatric patients with sepsis and disseminated intravascular coagulation.脓毒症和弥散性血管内凝血患儿的全球纤溶能力
Blood Coagul Fibrinolysis. 2006 Oct;17(7):569-73. doi: 10.1097/01.mbc.0000245304.95138.cf.

引用本文的文献

1
Clinical Application of Clot Waveform Analysis.血栓波形分析的临床应用
Clin Appl Thromb Hemost. 2025 Jan-Dec;31:10760296251331606. doi: 10.1177/10760296251331606. Epub 2025 Apr 1.
2
C3AR1 is a regulatory factor associated with coagulation cascade and inflammation in sepsis.C3AR1 是脓毒症凝血级联反应和炎症相关的调节因子。
Medicine (Baltimore). 2024 Mar 15;103(11):e37519. doi: 10.1097/MD.0000000000037519.
3
The impact of vascular endothelial glycocalyx on the pathogenesis and treatment of disseminated intravascular coagulation.
血管内皮糖萼对弥散性血管内凝血发病机制和治疗的影响。
Blood Coagul Fibrinolysis. 2023 Dec 1;34(8):465-470. doi: 10.1097/MBC.0000000000001257. Epub 2023 Sep 28.
4
Clot Waveform Analysis for Hemostatic Abnormalities.血栓波形态分析用于止血异常。
Ann Lab Med. 2023 Nov 1;43(6):531-538. doi: 10.3343/alm.2023.43.6.531. Epub 2023 Jun 30.